This article evaluates the analytical performance of a new ADVIA immunoassay for measuring cardiac troponin I.
Answers are grounded in this paper and cite their sources.
Analytical validation of the new troponin I assay supports lab adoption; leaves open clinical outcome studies before routine use.
Article Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin I was published on September 1, 2018 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 56, issue 9).
No takes yet. Share an insight, caveat, or question.
Musetti et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: